Making top-quality cancer care accessible to all.100% free, no account required.

Boosting Recovery with Robotic Surgery for Head and Neck Tumors

NCT01473784 · Recruiting
About this trial

This clinical trial studies a type of surgery called transoral robotic surgery (TORS) for patients with tumors in the head and neck. TORS is a less invasive approach, meaning it may cause fewer side effects and help patients recover faster. This trial is looking at how well this surgery works for both benign (non-cancerous) and malignant (cancerous) tumors.

Locations and contact

This trial is running at 1 location in the United States. It is currently recruiting.

United States1 location · 1 recruiting
  • Ohio State University Medical CenterColumbus, OhioRecruiting
Who to ask about joining
Ohio State University Comprehensive Cancer Center1-800-293-5066OSUCCCClinicaltrials@osumc.edu
Who can join

Adults aged 18 and older can join this trial. It is open to both men and women. Patients should have tumors in the oral cavity or throat that can be treated with this robotic surgery. Some patients may not be eligible if they have infections, are pregnant, or have had certain previous surgeries. The trial team will confirm who is eligible to participate.

What happens during the trial

Everyone in the trial will have the TORS procedure using the Da Vinci Robotic Surgical System. After surgery, patients will have regular check-ups to see how they are doing. They will also complete a quality of life assessment, which is a way to understand how the surgery affects their daily lives. If patients cannot go to the hospital for follow-up, they will receive a phone call or a questionnaire in the mail to complete.

The trial team

The trial is run by the Ohio State University Comprehensive Cancer Center. The principal investigator is Dr. Enver Ozer, who is affiliated with Ohio State University.

Important dates

The trial started on December 3, 2007, and is expected to finish by December 31, 2026. It is currently enrolling new participants.

Additional information

The trial's ID number is NCT01473784. It is not FDA-regulated for drugs or devices. The trial hopes to include about 600 participants.

Similar trials

Other recruiting trials for the same condition, with the eligibility rules written in plain language.

Browse similar trials
Talk to a specialist

Find a top oncologist who can tell you whether a trial is a sensible option for you.

Find a doctor
Cancer hospitals

The cancer centers running studies like this one, and what each is known for.

Browse hospitals